Relx Plc $RELX Shares Purchased by American Century Companies Inc.

American Century Companies Inc. raised its holdings in shares of Relx Plc (NYSE:RELX) by 9.8% during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 462,477 shares of the technology company’s stock after buying an additional 41,207 shares during the period. American Century Companies Inc.’s holdings in Relx were worth $25,131,000 at the end of the most recent reporting period.

Several other institutional investors also recently bought and sold shares of RELX. ABC Arbitrage SA raised its stake in shares of Relx by 188.9% in the 2nd quarter. ABC Arbitrage SA now owns 560,958 shares of the technology company’s stock valued at $30,482,000 after acquiring an additional 366,761 shares during the period. Ameriprise Financial Inc. boosted its position in Relx by 8.3% during the 1st quarter. Ameriprise Financial Inc. now owns 3,041,132 shares of the technology company’s stock worth $154,129,000 after purchasing an additional 234,094 shares during the period. Connor Clark & Lunn Investment Management Ltd. increased its holdings in Relx by 103.4% in the 1st quarter. Connor Clark & Lunn Investment Management Ltd. now owns 444,360 shares of the technology company’s stock valued at $22,400,000 after purchasing an additional 225,947 shares in the last quarter. Evelyn Partners Asset Management Ltd purchased a new position in Relx in the second quarter valued at about $11,649,000. Finally, Northern Trust Corp raised its position in Relx by 9.2% in the first quarter. Northern Trust Corp now owns 2,394,097 shares of the technology company’s stock valued at $120,686,000 after purchasing an additional 202,509 shares during the period. 15.02% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several equities research analysts have recently weighed in on the company. Kepler Capital Markets raised Relx from a “hold” rating to a “strong-buy” rating in a research report on Thursday, September 18th. Wall Street Zen lowered Relx from a “buy” rating to a “hold” rating in a research report on Saturday, November 8th. Weiss Ratings restated a “hold (c+)” rating on shares of Relx in a report on Tuesday, November 25th. Morgan Stanley reaffirmed an “overweight” rating on shares of Relx in a research report on Thursday, September 11th. Finally, Barclays reissued an “overweight” rating on shares of Relx in a research report on Tuesday, October 7th. One equities research analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating and one has given a Hold rating to the company’s stock. According to data from MarketBeat.com, Relx presently has an average rating of “Buy”.

Relx Price Performance

Shares of RELX opened at $40.29 on Monday. The company has a quick ratio of 0.42, a current ratio of 0.47 and a debt-to-equity ratio of 2.55. The business’s 50 day moving average is $44.17 and its two-hundred day moving average is $48.76. Relx Plc has a 52-week low of $39.31 and a 52-week high of $56.33.

Relx Profile

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.